Home arrow Features/Opinion arrow Good for iPods, But Bad for Patients -- The Boston Globe
hr08000-152x558.gif
Good for iPods, But Bad for Patients -- The Boston Globe E-mail to friends
(0 votes)
John M. Maraganore, March 22 2008
 
Maraganore, who is CEO of biotech Alnylam Pharmaceuticals, says pending legislative moves spurred by the information technology industry could fundamentally change the ground rules for patent protection. These changes are at odds with what the life sciences needs to thrive, and could decimate the industry.
Read Article

Digg!Del.icio.us!Google!Live!Facebook!StumbleUpon!Yahoo!Netvouz!Ma.gnolia!



Submit your own comment

Leave a Comment
Name:
E-mail:
Comment Title:
Comment:

Code:* Code
Plan Comparison Grid
image

Featured Podcast

Kim Slocum
Current State and Prospects for Consumer Directed Health Care
Kim D. Slocum, President of KDS Consulting speaks with Malorye Allison, editor-in-chief of ReformPlans.com. listen

More Podcasts

More Podcasts